FBInvestor
Stocks / Silexion Therapeutics Corp
Institutional Ownership

Silexion Therapeutics Corp

CUSIP G1281K130ORD SHS NEWQ1 2026

Earnings

Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).

Coming soon